Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SRx Health Solutions (SRXH) Change in Accured Expenses (2017 - 2025)

SRx Health Solutions (SRXH) has disclosed Change in Accured Expenses for 15 consecutive years, with $70000.0 as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Change in Accured Expenses fell 68.18% year-over-year to $70000.0, compared with a TTM value of $628000.0 through Jun 2025, up 141.53%, and an annual FY2023 reading of -$760000.0, down 867.68% over the prior year.
  • Change in Accured Expenses was $70000.0 for Q2 2025 at SRx Health Solutions, up from $67000.0 in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $1.3 million in Q2 2023 and bottomed at -$1.1 million in Q1 2023.
  • Average Change in Accured Expenses over 4 years is -$80000.0, with a median of $53000.0 recorded in 2022.
  • The sharpest move saw Change in Accured Expenses crashed 1861.54% in 2023, then surged 180.18% in 2024.
  • Year by year, Change in Accured Expenses stood at $39000.0 in 2022, then plummeted by 1861.54% to -$687000.0 in 2023, then soared by 139.45% to $271000.0 in 2024, then plummeted by 74.17% to $70000.0 in 2025.
  • Business Quant data shows Change in Accured Expenses for SRXH at $70000.0 in Q2 2025, $67000.0 in Q1 2025, and $271000.0 in Q3 2024.